The FDA declined to consider elamipretide for full approval in 2021 and rejected the company's application in May of 2025 ...

T he FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare ...

Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...

The FDA announced it will relax certain rules for approving low-cost versions of some high-priced medications.

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...

The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by ...